Mineralys Therapeutics Inc (MLYS)
followers
·
Follow
| Sector: | HEALTH CARE |
| Industry: | PHARMACEUTICALS |
| SIC: | PHARMACEUTICAL PREPARATIONS |
| CEO: | Jon Congleton |
| Employees: | |
| Web site: | mineralystx.com |
|
150 N. RADNOR CHESTER ROAD, SUITE F200, RADNOR, PA, 19087
(888) 378-6240
| |
| All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
|---|
We are a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. We were originally founded as a Delaware corporation on May 31, 2019 under the name Catalys SC1, Inc. On May 29, 2020, we changed our name to Mineralys Therapeutics, Inc. Our principal executive offices are located at 150 N. Radnor Chester Road, Suite F200, Radnor, PA.
Please log in first to see chart